Use of Drugs Targeted to Inhibit Different Stages of the HIV Life Cycle in the Treatment of AIDS View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1992

AUTHORS

Prem S. Sarin , Allan Goldstein , S. Agrawal , Paul Zamecnik

ABSTRACT

Acquired immune deficiency syndrome (AIDS) is a global disease which has presented extraordinary challenge to the scientific community in terms of understanding the pathogenesis, treatment and prevention of the disease. With the identification of human immunodeficiency virus (HIV) as the etiological agent (1–3), it is now possible to investigate approaches to develop treatments for the disease and vaccines for the prevention of the disease. With an estimated six to ten million HIV-1 infected individuals worldwide and over 160,000 known cases of AIDS in the United States, it is extremely important and urgent to look for strategies to control the disease by antiviral therapy. More... »

PAGES

123-129

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4615-3340-5_15

DOI

http://dx.doi.org/10.1007/978-1-4615-3340-5_15

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1032286833


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Microbiology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Dept. of Biochemistry and Molecular Biology, The George Washington University Medical Center, Washington, Washington, DC, USA", 
          "id": "http://www.grid.ac/institutes/grid.411841.9", 
          "name": [
            "Dept. of Biochemistry and Molecular Biology, The George Washington University Medical Center, Washington, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sarin", 
        "givenName": "Prem S.", 
        "id": "sg:person.01070617765.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070617765.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dept. of Biochemistry and Molecular Biology, The George Washington University Medical Center, Washington, Washington, DC, USA", 
          "id": "http://www.grid.ac/institutes/grid.411841.9", 
          "name": [
            "Dept. of Biochemistry and Molecular Biology, The George Washington University Medical Center, Washington, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goldstein", 
        "givenName": "Allan", 
        "id": "sg:person.07505661752.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07505661752.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Worcester Foundation for Experimental Biology, 01545, Shrewsbury, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.168645.8", 
          "name": [
            "Worcester Foundation for Experimental Biology, 01545, Shrewsbury, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Agrawal", 
        "givenName": "S.", 
        "id": "sg:person.01124454740.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124454740.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Worcester Foundation for Experimental Biology, 01545, Shrewsbury, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.168645.8", 
          "name": [
            "Worcester Foundation for Experimental Biology, 01545, Shrewsbury, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zamecnik", 
        "givenName": "Paul", 
        "id": "sg:person.0775656175.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775656175.54"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1992", 
    "datePublishedReg": "1992-01-01", 
    "description": "Acquired immune deficiency syndrome (AIDS) is a global disease which has presented extraordinary challenge to the scientific community in terms of understanding the pathogenesis, treatment and prevention of the disease. With the identification of human immunodeficiency virus (HIV) as the etiological agent (1\u20133), it is now possible to investigate approaches to develop treatments for the disease and vaccines for the prevention of the disease. With an estimated six to ten million HIV-1 infected individuals worldwide and over 160,000 known cases of AIDS in the United States, it is extremely important and urgent to look for strategies to control the disease by antiviral therapy.", 
    "editor": [
      {
        "familyName": "Goldstein", 
        "givenName": "Allan L.", 
        "type": "Person"
      }, 
      {
        "familyName": "Garaci", 
        "givenName": "Enrico", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4615-3340-5_15", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4613-6472-6", 
        "978-1-4615-3340-5"
      ], 
      "name": "Combination Therapies", 
      "type": "Book"
    }, 
    "keywords": [
      "human immunodeficiency virus", 
      "HIV-1 infected individuals", 
      "immune deficiency syndrome", 
      "cases of AIDS", 
      "HIV life cycle", 
      "use of drugs", 
      "treatment of AIDS", 
      "antiviral therapy", 
      "immunodeficiency virus", 
      "deficiency syndrome", 
      "infected individuals", 
      "disease", 
      "global disease", 
      "etiological agent", 
      "treatment", 
      "AIDS", 
      "prevention", 
      "syndrome", 
      "pathogenesis", 
      "vaccine", 
      "therapy", 
      "drugs", 
      "virus", 
      "United States", 
      "different stages", 
      "agents", 
      "individuals", 
      "extraordinary challenges", 
      "cases", 
      "use", 
      "stage", 
      "identification", 
      "strategies", 
      "scientific community", 
      "life cycle", 
      "challenges", 
      "cycle", 
      "community", 
      "approach", 
      "state", 
      "terms"
    ], 
    "name": "Use of Drugs Targeted to Inhibit Different Stages of the HIV Life Cycle in the Treatment of AIDS", 
    "pagination": "123-129", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1032286833"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4615-3340-5_15"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4615-3340-5_15", 
      "https://app.dimensions.ai/details/publication/pub.1032286833"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-11-24T21:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/chapter/chapter_93.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4615-3340-5_15"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4615-3340-5_15'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4615-3340-5_15'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4615-3340-5_15'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4615-3340-5_15'


 

This table displays all metadata directly associated to this object as RDF triples.

129 TRIPLES      22 PREDICATES      66 URIs      59 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4615-3340-5_15 schema:about anzsrc-for:11
2 anzsrc-for:1108
3 schema:author N56eeb77ee88548819f42c10746726b14
4 schema:datePublished 1992
5 schema:datePublishedReg 1992-01-01
6 schema:description Acquired immune deficiency syndrome (AIDS) is a global disease which has presented extraordinary challenge to the scientific community in terms of understanding the pathogenesis, treatment and prevention of the disease. With the identification of human immunodeficiency virus (HIV) as the etiological agent (1–3), it is now possible to investigate approaches to develop treatments for the disease and vaccines for the prevention of the disease. With an estimated six to ten million HIV-1 infected individuals worldwide and over 160,000 known cases of AIDS in the United States, it is extremely important and urgent to look for strategies to control the disease by antiviral therapy.
7 schema:editor Nfb6e72f0ec644e1cabf9528b817e03e3
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N4ff4fc2c88a34b548ec680c1eb40a3dc
11 schema:keywords AIDS
12 HIV life cycle
13 HIV-1 infected individuals
14 United States
15 agents
16 antiviral therapy
17 approach
18 cases
19 cases of AIDS
20 challenges
21 community
22 cycle
23 deficiency syndrome
24 different stages
25 disease
26 drugs
27 etiological agent
28 extraordinary challenges
29 global disease
30 human immunodeficiency virus
31 identification
32 immune deficiency syndrome
33 immunodeficiency virus
34 individuals
35 infected individuals
36 life cycle
37 pathogenesis
38 prevention
39 scientific community
40 stage
41 state
42 strategies
43 syndrome
44 terms
45 therapy
46 treatment
47 treatment of AIDS
48 use
49 use of drugs
50 vaccine
51 virus
52 schema:name Use of Drugs Targeted to Inhibit Different Stages of the HIV Life Cycle in the Treatment of AIDS
53 schema:pagination 123-129
54 schema:productId N969e3a89262341feb52d13e02cd61d5e
55 Nd3e23088f9724c45886227401f656598
56 schema:publisher Nf3f95eec9c774d82828ab4030a654c2f
57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032286833
58 https://doi.org/10.1007/978-1-4615-3340-5_15
59 schema:sdDatePublished 2022-11-24T21:20
60 schema:sdLicense https://scigraph.springernature.com/explorer/license/
61 schema:sdPublisher N758e9fe749dc4b4db5a8d9263f5dd1d3
62 schema:url https://doi.org/10.1007/978-1-4615-3340-5_15
63 sgo:license sg:explorer/license/
64 sgo:sdDataset chapters
65 rdf:type schema:Chapter
66 N17ef2377c3c049a28825b0124c4195ca schema:familyName Garaci
67 schema:givenName Enrico
68 rdf:type schema:Person
69 N4ff4fc2c88a34b548ec680c1eb40a3dc schema:isbn 978-1-4613-6472-6
70 978-1-4615-3340-5
71 schema:name Combination Therapies
72 rdf:type schema:Book
73 N56eeb77ee88548819f42c10746726b14 rdf:first sg:person.01070617765.41
74 rdf:rest Ndf2e05b4c6a94f40b9978d115feee06e
75 N5e0a816176c2400a8bb0d85e94d68b6a schema:familyName Goldstein
76 schema:givenName Allan L.
77 rdf:type schema:Person
78 N67798975aeae48d3b0b0f672583782dd rdf:first N17ef2377c3c049a28825b0124c4195ca
79 rdf:rest rdf:nil
80 N73b17f2e89dc45d6984e4f1fb73bcc92 rdf:first sg:person.0775656175.54
81 rdf:rest rdf:nil
82 N758e9fe749dc4b4db5a8d9263f5dd1d3 schema:name Springer Nature - SN SciGraph project
83 rdf:type schema:Organization
84 N969e3a89262341feb52d13e02cd61d5e schema:name doi
85 schema:value 10.1007/978-1-4615-3340-5_15
86 rdf:type schema:PropertyValue
87 Nd3e23088f9724c45886227401f656598 schema:name dimensions_id
88 schema:value pub.1032286833
89 rdf:type schema:PropertyValue
90 Nd4b4630eeb2e4268aa64e2f9bb8d842e rdf:first sg:person.01124454740.04
91 rdf:rest N73b17f2e89dc45d6984e4f1fb73bcc92
92 Ndf2e05b4c6a94f40b9978d115feee06e rdf:first sg:person.07505661752.04
93 rdf:rest Nd4b4630eeb2e4268aa64e2f9bb8d842e
94 Nf3f95eec9c774d82828ab4030a654c2f schema:name Springer Nature
95 rdf:type schema:Organisation
96 Nfb6e72f0ec644e1cabf9528b817e03e3 rdf:first N5e0a816176c2400a8bb0d85e94d68b6a
97 rdf:rest N67798975aeae48d3b0b0f672583782dd
98 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
99 schema:name Medical and Health Sciences
100 rdf:type schema:DefinedTerm
101 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
102 schema:name Medical Microbiology
103 rdf:type schema:DefinedTerm
104 sg:person.01070617765.41 schema:affiliation grid-institutes:grid.411841.9
105 schema:familyName Sarin
106 schema:givenName Prem S.
107 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070617765.41
108 rdf:type schema:Person
109 sg:person.01124454740.04 schema:affiliation grid-institutes:grid.168645.8
110 schema:familyName Agrawal
111 schema:givenName S.
112 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124454740.04
113 rdf:type schema:Person
114 sg:person.07505661752.04 schema:affiliation grid-institutes:grid.411841.9
115 schema:familyName Goldstein
116 schema:givenName Allan
117 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07505661752.04
118 rdf:type schema:Person
119 sg:person.0775656175.54 schema:affiliation grid-institutes:grid.168645.8
120 schema:familyName Zamecnik
121 schema:givenName Paul
122 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775656175.54
123 rdf:type schema:Person
124 grid-institutes:grid.168645.8 schema:alternateName Worcester Foundation for Experimental Biology, 01545, Shrewsbury, MA, USA
125 schema:name Worcester Foundation for Experimental Biology, 01545, Shrewsbury, MA, USA
126 rdf:type schema:Organization
127 grid-institutes:grid.411841.9 schema:alternateName Dept. of Biochemistry and Molecular Biology, The George Washington University Medical Center, Washington, Washington, DC, USA
128 schema:name Dept. of Biochemistry and Molecular Biology, The George Washington University Medical Center, Washington, Washington, DC, USA
129 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...